Trial Profile
A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2011
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary) ; Methyl aminolevulinate (Primary)
- Indications Basal cell cancer; Bowen's disease
- Focus Therapeutic Use
- 07 Mar 2011 New trial record